Australia
· Delayed Price · Currency is AUD Argenica Therapeutics Statistics
Total Valuation
ASX:AGN has a market cap or net worth of AUD 81.98 million. The enterprise value is 66.90 million.
| Market Cap | 81.98M |
| Enterprise Value | 66.90M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:AGN has 128.09 million shares outstanding. The number of shares has increased by 46.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 128.09M |
| Shares Change (YoY) | +46.14% |
| Shares Change (QoQ) | +16.78% |
| Owned by Insiders (%) | 25.09% |
| Owned by Institutions (%) | 18.39% |
| Float | 91.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.62 |
| PB Ratio | 6.21 |
| P/TBV Ratio | 6.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.73 |
| EV / Sales | 21.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.95
| Current Ratio | 6.95 |
| Quick Ratio | 6.92 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12,573.18 |
Financial Efficiency
Return on equity (ROE) is -53.14% and return on invested capital (ROIC) is -35.82%.
| Return on Equity (ROE) | -53.14% |
| Return on Assets (ROA) | -29.50% |
| Return on Invested Capital (ROIC) | -35.82% |
| Return on Capital Employed (ROCE) | -42.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.27% in the last 52 weeks. The beta is 0.82, so ASX:AGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +13.27% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 34.96 |
| Average Volume (20 Days) | 113,742 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:AGN had revenue of AUD 3.08 million and -5.26 million in losses. Loss per share was -0.04.
| Revenue | 3.08M |
| Gross Profit | 3.08M |
| Operating Income | -5.67M |
| Pretax Income | -5.26M |
| Net Income | -5.26M |
| EBITDA | n/a |
| EBIT | -5.67M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 15.08 million in cash and n/a in debt, giving a net cash position of 15.08 million or 0.12 per share.
| Cash & Cash Equivalents | 15.08M |
| Total Debt | n/a |
| Net Cash | 15.08M |
| Net Cash Per Share | 0.12 |
| Equity (Book Value) | 13.19M |
| Book Value Per Share | 0.10 |
| Working Capital | 13.19M |
Cash Flow
| Operating Cash Flow | -5.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -184.14% and -170.72%.
| Gross Margin | 100.00% |
| Operating Margin | -184.14% |
| Pretax Margin | -170.72% |
| Profit Margin | -170.72% |
| EBITDA Margin | n/a |
| EBIT Margin | -184.14% |
| FCF Margin | n/a |
Dividends & Yields
ASX:AGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.14% |
| Shareholder Yield | -46.14% |
| Earnings Yield | -6.41% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:AGN has an Altman Z-Score of 21.01.
| Altman Z-Score | 21.01 |
| Piotroski F-Score | n/a |